DE2323924A1 - Wiedersuspendierbare getrocknete antiacidische mischungen - Google Patents
Wiedersuspendierbare getrocknete antiacidische mischungenInfo
- Publication number
- DE2323924A1 DE2323924A1 DE2323924A DE2323924A DE2323924A1 DE 2323924 A1 DE2323924 A1 DE 2323924A1 DE 2323924 A DE2323924 A DE 2323924A DE 2323924 A DE2323924 A DE 2323924A DE 2323924 A1 DE2323924 A1 DE 2323924A1
- Authority
- DE
- Germany
- Prior art keywords
- alcohol
- dried
- gel
- carbonate
- aluminum hydroxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims description 35
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 41
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 40
- 229940069428 antacid Drugs 0.000 claims description 40
- 239000003159 antacid agent Substances 0.000 claims description 40
- 230000001458 anti-acid effect Effects 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 27
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 15
- 239000000725 suspension Substances 0.000 claims description 15
- 229940024545 aluminum hydroxide Drugs 0.000 claims description 14
- 229940024546 aluminum hydroxide gel Drugs 0.000 claims description 14
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 13
- 239000000395 magnesium oxide Substances 0.000 claims description 12
- FGIVSRGEPDCSNW-UHFFFAOYSA-K aluminum;hydrogen carbonate;carbonate Chemical compound [Al+3].OC([O-])=O.[O-]C([O-])=O FGIVSRGEPDCSNW-UHFFFAOYSA-K 0.000 claims description 10
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 claims description 10
- 239000000347 magnesium hydroxide Substances 0.000 claims description 10
- 229910001862 magnesium hydroxide Inorganic materials 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 229910052782 aluminium Inorganic materials 0.000 claims description 8
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000007900 aqueous suspension Substances 0.000 claims description 5
- 235000013305 food Nutrition 0.000 claims description 5
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 5
- 239000001095 magnesium carbonate Substances 0.000 claims description 5
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 5
- GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 claims description 3
- 239000000391 magnesium silicate Substances 0.000 claims description 3
- 229940099273 magnesium trisilicate Drugs 0.000 claims description 3
- 229910000386 magnesium trisilicate Inorganic materials 0.000 claims description 3
- 235000019793 magnesium trisilicate Nutrition 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 6
- 229940058015 1,3-butylene glycol Drugs 0.000 claims 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 235000019437 butane-1,3-diol Nutrition 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- -1 aluminum hydroxybicarbonate carbonate Chemical compound 0.000 claims 1
- 238000002036 drum drying Methods 0.000 claims 1
- 239000000499 gel Substances 0.000 description 48
- 238000000926 separation method Methods 0.000 description 24
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 20
- 235000011187 glycerol Nutrition 0.000 description 20
- 238000003756 stirring Methods 0.000 description 15
- 239000000843 powder Substances 0.000 description 14
- 239000008367 deionised water Substances 0.000 description 10
- 229910021641 deionized water Inorganic materials 0.000 description 10
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 9
- MXRIRQGCELJRSN-UHFFFAOYSA-N O.O.O.[Al] Chemical compound O.O.O.[Al] MXRIRQGCELJRSN-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000011777 magnesium Substances 0.000 description 7
- 235000012254 magnesium hydroxide Nutrition 0.000 description 7
- 206010016322 Feeling abnormal Diseases 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 4
- WKHMXCIUCCIPOU-UHFFFAOYSA-N perfluoro-1-methyladamantane Chemical compound FC1(F)C(C2(F)F)(F)C(F)(F)C3(F)C(F)(F)C2(F)C(F)(F)C1(C(F)(F)F)C3(F)F WKHMXCIUCCIPOU-UHFFFAOYSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000014380 magnesium carbonate Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- DNFYYVUKMVYWPY-UHFFFAOYSA-I aluminum;magnesium;carbonate;trihydroxide Chemical compound [OH-].[OH-].[OH-].[Mg+2].[Al+3].[O-]C([O-])=O DNFYYVUKMVYWPY-UHFFFAOYSA-I 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 239000000292 calcium oxide Substances 0.000 description 2
- 235000012255 calcium oxide Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000009533 lab test Methods 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 229910052573 porcelain Inorganic materials 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000011240 wet gel Substances 0.000 description 2
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical class [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 229940108928 copper Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000014987 copper Nutrition 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- OGWLTJRQYVEDMR-UHFFFAOYSA-F tetramagnesium;tetracarbonate Chemical compound [Mg+2].[Mg+2].[Mg+2].[Mg+2].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O OGWLTJRQYVEDMR-UHFFFAOYSA-F 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PH15824*A PH9912A (en) | 1973-05-11 | 1974-05-10 | Animal feed |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25281672A | 1972-05-12 | 1972-05-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2323924A1 true DE2323924A1 (de) | 1973-11-29 |
Family
ID=22957672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2323924A Pending DE2323924A1 (de) | 1972-05-12 | 1973-05-11 | Wiedersuspendierbare getrocknete antiacidische mischungen |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4112072A (enExample) |
| JP (1) | JPS4947517A (enExample) |
| AU (1) | AU5526173A (enExample) |
| BE (1) | BE799393A (enExample) |
| CA (1) | CA1006814A (enExample) |
| DE (1) | DE2323924A1 (enExample) |
| ES (1) | ES414655A1 (enExample) |
| FR (1) | FR2184719B1 (enExample) |
| GB (1) | GB1408983A (enExample) |
| IT (1) | IT1046107B (enExample) |
| NL (1) | NL7306703A (enExample) |
| ZA (1) | ZA733219B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6051767B2 (ja) * | 1976-08-17 | 1985-11-15 | 松下電子工業株式会社 | 無紫外線けい光ランプの製造方法 |
| CA1174975A (en) * | 1981-08-03 | 1984-09-25 | Andrew M. Rubino | Co-dried aluminum oxyhydroxides |
| US4676984A (en) * | 1985-08-14 | 1987-06-30 | American Home Products Corp. | Rehydratable antacid composition |
| US4704278A (en) * | 1984-10-17 | 1987-11-03 | American Home Products Corp (Del) | Fluidized magaldrate suspension |
| GB2201594B (en) * | 1986-06-24 | 1991-02-13 | Istvan Racz | Production of acid binding pharmaceutical preparations |
| HU196711B (en) * | 1986-06-24 | 1989-01-30 | Istvan Racz | Process for producing long-acting, gastric acid neutralizing pharmaceutics with high acid-binding capacity and increased bioavailability |
| HU197216B (en) * | 1986-12-22 | 1989-03-28 | Judit Starcz | Process for production of baked pastes with anticide effect |
| US6048552A (en) * | 1997-03-26 | 2000-04-11 | Chattem Chemicals, Inc. | DASC compositions, process for preparing same and suspensions containing same |
| US6110505A (en) * | 1997-04-01 | 2000-08-29 | Mcneil Ppc Inc. | Translucent antacid suspension containing co-dried dihydroxy aluminum sodium carbonate |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB784659A (en) * | 1954-11-26 | 1957-10-16 | Upjohn Co | Therapeutic compositions and aqueous suspensions thereof |
| US3239416A (en) * | 1963-05-29 | 1966-03-08 | Armour Pharma | Aluminum hydroxide-metal hydroxide antacid and process of making the same |
| US3272704A (en) * | 1963-06-06 | 1966-09-13 | Armour Pharma | Stable aluminum hydroxide-magnesium compound codried gel antacids and process of making the same |
| US3452138A (en) * | 1964-08-26 | 1969-06-24 | Bristol Myers Co | Urea-containing chewable antacid tablets |
| US3579634A (en) * | 1968-04-18 | 1971-05-18 | Garland Richard Brown | Novel antacid compositions and methods for their administration |
| US3599150A (en) * | 1969-08-01 | 1971-08-10 | Miles Lab | Stabilized aluminum hydroxide suspensions |
-
1973
- 1973-05-04 AU AU55261/73A patent/AU5526173A/en not_active Expired
- 1973-05-11 IT IT23997/73A patent/IT1046107B/it active
- 1973-05-11 ES ES414655A patent/ES414655A1/es not_active Expired
- 1973-05-11 FR FR7317108A patent/FR2184719B1/fr not_active Expired
- 1973-05-11 GB GB2252173A patent/GB1408983A/en not_active Expired
- 1973-05-11 CA CA171,073A patent/CA1006814A/en not_active Expired
- 1973-05-11 ZA ZA733219A patent/ZA733219B/xx unknown
- 1973-05-11 BE BE2052761A patent/BE799393A/xx unknown
- 1973-05-11 DE DE2323924A patent/DE2323924A1/de active Pending
- 1973-05-12 JP JP48053049A patent/JPS4947517A/ja active Pending
- 1973-05-14 NL NL7306703A patent/NL7306703A/xx unknown
- 1973-12-10 US US05/423,226 patent/US4112072A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US4112072A (en) | 1978-09-05 |
| CA1006814A (en) | 1977-03-15 |
| ZA733219B (en) | 1974-06-26 |
| IT1046107B (it) | 1980-06-30 |
| AU5526173A (en) | 1974-11-07 |
| GB1408983A (en) | 1975-10-08 |
| BE799393A (fr) | 1973-08-31 |
| JPS4947517A (enExample) | 1974-05-08 |
| FR2184719B1 (enExample) | 1976-08-13 |
| NL7306703A (enExample) | 1973-11-14 |
| ES414655A1 (es) | 1976-06-01 |
| FR2184719A1 (enExample) | 1973-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69617659T4 (de) | Pharmazeutische zusammensetzungen, welche ausgewählte lanthancarbonathydrate enthalten | |
| DE69005394T2 (de) | Zusammensetzungen welche komplexe von hyaluronsäure enthalten und verfahren zu deren herstellung. | |
| DE2605386C2 (de) | Aluminium-Zirkon-Komplexe zur Verwendung als Antitranspirantien | |
| DE69004004T2 (de) | Kolloidales Fluorid und orale Zusammensetzung. | |
| DE3430809A1 (de) | Sucralfat-suspension | |
| CH647949A5 (de) | Cholestyramin-enthaltende pharmazeutische komposition. | |
| DE3751478T2 (de) | Herstellungsverfahren einer viskositätsstabilen antisäurezusammensetzung. | |
| DE2323924A1 (de) | Wiedersuspendierbare getrocknete antiacidische mischungen | |
| DE2325078C3 (de) | Verfahren zur Herstellung von Magnesium-aluminiumsilicat | |
| DE3586281T2 (de) | Antisaeurezusammensetzung. | |
| CH535048A (de) | Verfahren zur Herstellung eines kariostatischen Mittels | |
| DE2639505B2 (enExample) | ||
| US3239416A (en) | Aluminum hydroxide-metal hydroxide antacid and process of making the same | |
| DE2317768C3 (de) | Verfahren zur Herstellung eines antazid wirkenden Arzneimittels | |
| DE69013671T2 (de) | Bariumsulfat-kolloidale Dispersion enthaltende Zusammensetzung. | |
| DE3315606C2 (enExample) | ||
| EP0154114A2 (de) | Neues Verfahren zur Herstellung von Magaldrate | |
| DE2510663B2 (de) | Aluminiumpolyhydroxisulfat sowie dieses enthaltendes Arzneimittel | |
| DE69132837T2 (de) | Herstellung einer vorratslösung von in wasser suspendiertem sucralfat | |
| DE2743001A1 (de) | Verfahren zum faellen von calcium- aluminium-antisaeuremitteln | |
| US3066073A (en) | Antacid:calcium phosphate gelmagnesium trisilicate | |
| US3272703A (en) | Antacid composition and process of making the same | |
| DE69100053T2 (de) | Arzneimittelzusammensetzung in stabiler wässriger Suspensionsform auf der Basis von Sucralfat und einem Antacidum sowie Verfahren zu ihrer Herstellung. | |
| DE1617277C3 (de) | Verfahren zur Herstellung eines flüssigen Antazidums | |
| DE3873279T2 (de) | Orales adsorbens fuer phosphat-ionen. |